Citadel Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Citadel Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-45,657	Closed	-$3.42M	–	9746
2015 Q3	$3.42M	Sell	45,657 -560,192	-92%	-$41.8M	﹤0.01%	2319
2015 Q2	$45.6M	Buy	605,849 +596,372	+6,293%	+$32M	0.04%	547
2015 Q1	$475K	Buy	+9,477	New	+$398K	﹤0.01%	4980
2014 Q4	–	Sell	-6,216	Closed	-$217K	–	8978
2014 Q3	$204K	Buy	+6,216	New	+$219K	﹤0.01%	5707
2014 Q2	–	Sell	-3,874	Closed	-$154K	–	8645
2014 Q1	$154K	Buy	3,874 +2,112	+120%	+$94.5K	﹤0.01%	5779
2013 Q4	$66K	Sell	1,762 -8,588	-83%	-$356K	﹤0.01%	5890
2013 Q3	$473K	Buy	+10,350	New	+$310K	﹤0.01%	3874

Citadel Advisors's KYTH Position: Q4 2015 in Review

Citadel Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 45,657 shares — an estimated $3.42M sold.

Citadel Advisors first reported a position in KYTH in Q3 2013 and held it in 7 quarters. The position peaked at $45.6M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Citadel Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Citadel Advisors sold 45,657 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $3.42M.
Citadel Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 7 quarters.
Citadel Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $45.6M in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Citadel Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.